Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trial.

Alkner S, de Boniface J, Lundstedt D, Mjaaland I, Ryden L, Vikstrom J, Bendahl PO, Holmberg E, Sackey H, Wieslander E, Karlsson P

Open source

DOI
10.1136/bmjopen-2023-075543
Published
2023 Sep 26
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2023-075543,
  title = {Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trial.},
  author = {Alkner S and de Boniface J and Lundstedt D and Mjaaland I and Ryden L and Vikstrom J and Bendahl PO and Holmberg E and Sackey H and Wieslander E and Karlsson P},
  year = {2023},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2023-075543},
  url = {https://doi.org/10.1136/bmjopen-2023-075543}
}

RIS

TY  - JOUR
TI  - Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trial.
AU  - Alkner S
AU  - de Boniface J
AU  - Lundstedt D
AU  - Mjaaland I
AU  - Ryden L
AU  - Vikstrom J
AU  - Bendahl PO
AU  - Holmberg E
AU  - Sackey H
AU  - Wieslander E
AU  - Karlsson P
PY  - 2023
JO  - BMJ open
DO  - 10.1136/bmjopen-2023-075543
UR  - https://doi.org/10.1136/bmjopen-2023-075543
ER  - 

APA

S, A., J, D. B., D, L., I, M., L, R., J, V., PO, B., E, H., H, S., E, W., & P, K. (2023). Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trial.. BMJ open. https://doi.org/10.1136/bmjopen-2023-075543

Source records